Sarah Cannon and HCA Research Institute is a clinical research site located in Nashville, Tennessee, United States 37221.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon and HCA Research Institute has participated in 13 clinical trials with 9 currently active.
Therapeutic areas: Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer.
Sponsors: BicycleTx Limited, Matthew Neal MD, C4 Therapeutics, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon and HCA Research Institute has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon and HCA Research Institute has 13 clinical trials on record, with 9 currently active. Their work covers Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer.
Sarah Cannon and HCA Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.